Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease

by Naim Shehadeh, Itamar Raz, Afif Nakhleh
Published 2018-08-01

Guillain Barré Syndrome in a Child With X-Linked Adrenoleukodystrophy

by Ron Jacob MD, Hanna Mandel MD, Naim Shehadeh MD
Published 2015-10-01

ACTION-IO as a platform to understand differences in perceptions, attitudes, and behaviors of people with obesity and physicians across countries – the Israeli experience

by Dror Dicker, Batya Kornboim, Rakefet Bachrach, Naim Shehadeh, Shani Potesman-Yona, Gabriella Segal-Lieberman
Published 2020-10-01

Effect of Socioeconomic Status and Ethnicity on Glycemic Control in Arab and Jewish Youth with Type 1 Diabetes Mellitus

by Nehama Zuckerman-Levin, Haleema Dabaja-Younis, Elemy Ameer, Michal Cohen, Yasmin Maor, Naim Shehadeh
Published 2018-10-01

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

by Guntram Schernthaner, Naim Shehadeh, Alexander S. Ametov, Anna V. Bazarova, Fahim Ebrahimi, Peter Fasching, Andrej Janež, Péter Kempler, Ilze Konrāde, Nebojša M. Lalić, Boris Mankovsky, Emil Martinka, Dario Rahelić, Cristian Serafinceanu, Jan Škrha, Tsvetalina Tankova, Žydrūnė Visockienė
Published 2020-10-01